VRME News and Press, VerifyMe Inc. From 10/06/22

VerifyMe ( NASDAQ: VRME ) with its wholly owned subsidiary PeriShip Global has entered into an agreement with an international luxury apparel company to provide brand protection solutions. The company will provide its brand protection labels with dynamic QR codes to an int...

VerifyMe Enters into Contract with International Luxury Apparel Company PR Newswire ROCHESTER, N.Y. , Oct. 6, 2022 /PRNewswire/ -- VerifyMe, Inc . (NASDAQ: VRME ) ("VerifyMe," "we," "our," or the "Company"), together with its wholly owned subsidia...

VerifyMe ( NASDAQ: VRME ) with its wholly owned subsidiary PeriShip Global has entered into a new debt facility with PNC Bank, National Association and repaid all outstanding principal and interest on the promissory note issued in connection with the PeriShip acquisition. ...

VerifyMe Subsidiary Enters into a $2 million Term Loan Agreement and a $1 million line of credit with PNC Bank and Repays $2.0 million promissory note from PeriShip Acquisition PR Newswire ROCHESTER, N.Y. , Sept. 27, 2022 /PRNewswire/ -- VerifyMe, Inc ...

VerifyMe ( NASDAQ: VRME ) announced Wednesday that it has signed a new multi-year extension of their professional services deal with the strategic partner. The term of the agreement, originally scheduled to expire on March 1, 2024, has been extended to March&...

VerifyMe Enters into Multi-Year Contract Extension with Strategic Partner and Largest Customer of PeriShip PR Newswire ROCHESTER, N.Y. , Aug. 31, 2022 /PRNewswire/ -- VerifyMe, Inc . (NASDAQ: VRME) ("VerifyMe," "we," "our," or the "Company"), together...

SciSparc ( SPRC ) +41% Signs a Non- Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal. Viridian Therapeutics ( VRDN ) +32% as thyroid eye disease drug shows promise in trial. Helbiz ( HLBZ ...

VerifyMe Reports Significant Revenue Growth in Second Quarter 2022 Results PR Newswire Quarterly revenue of $4.5 million , compared to $0.1 million in Q2 2021 Significant growth from acquisition while continuing organic growth trend Net Loss o...

Better Therapeutics ( BTTX ) +66% Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results. JAKKS Pacific ( JAKK ) +35% CEO Stephen Berman on Q2...

VerifyMe to Present at the 15th Annual Barrington Research Virtual Fall Conference PR Newswire ROCHESTER, N.Y. , July 18, 2022 /PRNewswire/ -- VerifyMe, Inc . (NASDAQ: VRME) ("VerifyMe," "we," "our," or the "Company"), together with its subsidiary Per...